Please login to the form below

Not currently logged in
Email:
Password:

Richard Vellacott joins Horizon Discovery as chief financial officer

His 15 years’ industry includes time in Deloitte’s life sciences practice

Cambridge, UK-based personalised medicine research tool firm Horizon Discovery has appointed Richard Vellacott as chief financial officer.

He was most recently vice president, finance at hi-tech company CSR, but joins Horizon with over 15 years' experience in working with life science companies.

During this time Vellacott served as a director in Deloitte's life sciences practice, where he specialised in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.

Horizon's CEO Dr Darrin Disley said: “I'm delighted to welcome Richard to Horizon. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Richard's background is an ideal fit and I very much look forward to working with him.”

8th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Free White Paper: Customer Experience for Pharma
To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more....
How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....